If Merck bid 60c a share cash.............., page-12

WHat is the sell price?

A very good question!

If there was a smidgeon of good news,such as a milestone payment of $20m from Merck or there was soem meaningful information announced about sale of oncology assets, theen stock could pop to perhas 50-60c.

If stock managed to get soem positive news, and there was a break throght the resistance in low 40c area, then I thinkl the stock can track higher over 2018 as speculators anticipate news from the PTSD trial.

It would not surprise me if stock headed above 60c ahead of the PTSD trial results.

If they are genuinely positive and not just a load of positive spin, then the stock could easily go through $1.00 IMHO.

There are plenty of caveats in my prognosis and the company actually has to deliver on a number of front - but there is serious upside in BNO this year - most likely in the next 6-9 months.

Perhaps enrollments in the PTSD trial are ahead of schedule and they close eff enrollments early - then the results will be available just that bit sooner.

But we do not know how well the enrollment process is going because the company in its infinite wisdom would not want to signal anything positive in case enrollments slowed again.

Its a bit tedious, but all of it makes me wonder if the Board really truly does believe in BNC 210.

They had better because they are in the process of making BNO a one shot company!

I find it very odd that the company can't attract new shareholders ahead of what should be a major watershed year................

Maybe its just me, but I find the lack of natural market interest worrying.

GLTA & DYOR